Václav Novotný is currently the CEO of Aspironix BioMed. Former Regional Executive Director for Switzerland, Austria and Central and Eastern Europe (revenue of $500 million) and member of the European leadership team of leading American biotechnology company Biogen (4 years). For twelve years, he served as the Executive Director of MSD (Merck & Co) in the Czech Republic and Slovakia. He also holds the position of Vice President of the American Chamber of Commerce in the Czech Republic. Vaclav also serves as the advisory board member of the Charles University Innovation Prague center.